Timed to World Arthritis Day, HCPLive looks at whether adding tirzepatide to ixekizumab could help calm psoriatic arthritis.
Recap by typeshit. Post by HCPLive on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
The Swiss drugmaker is licensing an investigational obesity candidate from the Chinese biotech, adding to its push into the weight loss drug race.
Obesity doctor Spencer Nadolsky weighs in on who has the standing to give advice on GLP-1 medications and peptides online.
Loading…